Search
Displaying results 351 to 360 of 1494.
Scientists from McGill University visit Braunschweig
A two-day symposium was the centrepiece of the recent visit. Scientists from HZI and McGill University presented their research on selected research topics related to infection including global health, the role of microbiota in infections and personalized medicine. “We…
Improved protection against influenza through mucous surface guards
The influenza vaccine with inactivated influenza viruses stimulates the immune system to produce antibodies against surface characteristics of the seasonal influenza strain. These surface characteristics are highly variable, meaning updated vaccines must be administered…
Double Chair for the Centre for Individualised Infection Medicine
For the two directors, concrete projects are at the forefront of the successful establishment of the centre. ”On the basis of pilot projects, we can shed light on the various aspects of the workflow to be set up, develop it gradually and finally settle it in the newly…
Research into antiviral agents
The rapid global spread of the pathogen SARS-CoV-2 has highlighted the importance of having effective drugs available to treat viral diseases. While the spread of SARS-CoV-2 has been mitigated by the rapid development of effective vaccines, this option does not yet…
Network of German Female Researchers in Infectious Diseases Established
Over the next three years, the German Federal Ministry of Education and Research will provide funding for the establishment of a network of German female researchers of infectious diseases with its Innovative Women in Focus program. RWTH Professor Gabriele Pradel from…
LOKI - Local Early Warning System for Control of Infection Outbreaks
”When a hazardous pathogen with epidemic or even pandemic potential emerges, it is most important to react as quickly as possible,” says Prof Michael Meyer-Hermann, head of the Department of Systems Immunology at the HZI. ”We are developing LOKI as an early warning…
Cell protection, immunomodulation and virus inhibition by an endogenous substance
"Itaconic acid has two isomers, natural relatives that differ only slightly in chemical structure, mesaconic and citraconic acid," says PD Dr. Frank Pessler, head of the working group "Biomarkers for Infectious Diseases" at the Institute for Experimental Infection…
The path to personalised hepatitis D treatment
Hepatitis D is caused by coinfection of hepatitis B patients with the hepatitis D virus (HDV). Up to 20 Million individuals are infected with HDV worldwide including about 250.000 patients in the European Union. There is very limited knowledge on disease pathophysiology…
COVID-19: Viral load in lungs supports prognosis in severely ill patients
You studied the viral load in different clinical samples from ventilated COVID-19 patients. What does viral load reveal about the clinical prognosis of patients? For which group of people does this apply? Henrike Maaß: Unfortunately, a clear clinical prognosis is not…
Two bugs with one stone
More and more cases of antibiotic-resistant bacterial pathogens are being reported worldwide. In order to ensure that effective antibiotics will still be available in the future, there is an urgent need to discover antimicrobial compounds with novel structures and…
